Analystreport

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its price target lowered by analysts at HC Wainwright from $28.00 to $26.00. They now have a "buy" rating on the s

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com